Sep 11, 2026
BrightPoint Revenue Model

The revenue model is based on razors (the hand-held reusable controller) and razor blades (the disposable fiber optic). We are not manufacturing needles (we will seek large needle manufacturers as potential partners).
The BrightPointTM Epidural device is used with existing FDA cleared needles & syringes.
The hand-held controller is a low cost, multi-use, medical device and has a two-year warranty. The fiber optic is a sterile, single-use disposable. The device will be covered under current reimbursement codes for epidural accessories.
Recent Posts

Focus on clinical training as a tool
Clinician Training Tool The go-to-market strategy is to focus initially on teaching hospitals. Teaching hospitals...

Market Research Focus Group Results
Before developing the current product, Lumoptik conducted 3 physician focus groups with 21 anesthesiologists and...

Product Design to Meet Market Needs
Based on the feedback from clinicians in the market research focus groups the Lumoptik BrightPoint™...